Newton Photonics
Chestnut Hill
About Newton Photonics
Newton Photonics is developing a truly non-invasive blood glucose monitor for diabetes patients. Newton Photonics is developing a non-invasive glucose monitor for diabetes patients. Their mission is to make self-testing of blood glucose as convenient and painless as blood oxygen testing with a pulse oximeter. Their glucose monitor is based on the company's proprietary optical sensing technology, which has been validated in two blind human trials. They currently seeks $200,000 to build and test their next generation prototype that will be more accurate, faster and smaller.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $149.8K
- Last round: Grant (Nov 2014)
- Website: newtonphotonics.com
- Phone: (617) 928-1221
Industries & Categories
Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/newton-photonics-2120587 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.